Crossmark

Proto-oncogene c-Myb potentiates cisplatin resistance of ovarian cancer cells by downregulating lncRNA NKILA and modulating cancer stemness and LIN28A-let7 axis

Crossref DOI link: https://doi.org/10.1186/s13048-024-01429-w

Published Online: 2024-05-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Xue-Yan

Zhu, Bo-Chi

He, Miao

Dong, Shan-Shan
Funding

Funding for this research was provided by:

Bethune Program of Jilin University (2020B07)

Health Commission of Jilin Province Health Technology Capacity Improvement Project (2022LC123)
License Information

Text and Data Mining valid from 2024-05-14

Version of Record valid from 2024-05-14
More Information

Article History

Received: 8 May 2023

Accepted: 30 April 2024

First Online: 14 May 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below